Cargando…
Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?
Autores principales: | Verma, Vivek, Chang, Joe Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867789/ https://www.ncbi.nlm.nih.gov/pubmed/33569287 http://dx.doi.org/10.21037/tlcr-2020-19 |
Ejemplares similares
-
Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy
por: Cai, Shuhua, et al.
Publicado: (2014) -
Postoperative Radiotherapy Omitting Level Ⅳ for Locally Advanced
Supraglottic and Glottic Laryngeal Carcinoma
por: Wu, Yang, et al.
Publicado: (2021) -
Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016) -
Barriers to Achieving Glycemic Targets: Who Omits Insulin and Why?
por: Weinger, Katie, et al.
Publicado: (2010) -
Clinical Outcome of Palliative Radiotherapy for Locally Advanced Symptomatic Gastric Cancer in the Modern Era
por: Tey, Jeremy, et al.
Publicado: (2014)